-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Edgewise Therapeutics, Maintains $45 Price Target

Benzinga·06/16/2026 15:57:09
Listen to the news
HC Wainwright & Co. analyst Lander Egaña Gorroño reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Buy and maintains $45 price target.